BORTEZOMIB for injection is a proteasome inhibitor indicated for:
- Treatment of patients with multiple myeloma (1.1)
- Treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy (1.2)
Please see full prescribing information here and here.
